Chapter 71 - Seizure & Epilepsy Flashcards

1
Q

Seizure types

A
  • Tonic - clonic: uncontrolled jerking movement
  • Absent: momentary loss of awareness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diagnostic tools

A
  • An electroencephalogram (EEG), the most common test used to diagnose epilepsy, records electrical activity in the brain.
  • An EEG can show abnormal patterns even when the patient is not having a seizure.
  • Brain imaging with a CT or MRI can identify some conditions that can provoke seizures, including brain tumors or damage from a stroke.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

DRUGS THAT CAN LOWER THE SEIZURE THRESHOLD

A
  • Bupropion
  • Clozapine
  • Theophylline
  • Varenicline
  • Carbapenems (esp. imipenem)*
  • Lithium*
  • Meperidine*
  • Penicillin*
  • Quinolones*
  • Tramadol*
  • Acyclovir
  • Cephalosporins
  • lindane
  • Mefloquine
  • Metoclopramide
  • Valacyclovir
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Classification of seizure

A

classified into three main types based on where the seizure starts in the brain:

1) Focal seizures
- Start on one side of the brain but can spread to the other side.
- Focal seizures are further classified based on the patient’s awareness during the seizure.
- If a focal seizure results in no loss of consciousness, it is called a focal aware seizure, previously known as a simple partial seizure.
- If the patient experiences loss of consciousness, it is called a focal seizure with impaired awareness, previously known as a complex partial seizure.

2) Generalized seizures
- Start on both sides of the brain
- Patients with generalized seizures experience loss of consciousness or are unaware during the seizure event.
- Absent seizure is a type of generalized

3) Unknown onset seizures
- if the location of the beginning of the seizure is not known (e.g., the seizures are unwitnessed or occur during the night).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

All seizure types can be described based on the patient’s symptoms.
motor and non motor sx

A

Motor symptoms include:
- Sustained rhythmical jerking movements (clonic)
- Limp or weak muscles (atonic)
- Muscle twitching (myoclonus)
- Rigid or tense muscles (tonic)

Non-motor symptoms include:
- Changes in sensation, emotions, thinking or cognition.

  • Generalized seizures with non-motor symptoms are called absence seizures, which typically present as staring spells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

seizure management

A
  • less than 2 min –> no ttmt needed
  • Status epilepticus (SE) is a seizure that lasts beyond five minutes because the normal mechanisms that terminate seizures are not working.
  • At 30 minutes, long-term damage can occur.

This is a medical emergency, and emergency treatment should begin with any seizure that lasts longer than five minutes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acute Seizure management

A
  • Initial treatment is a benzodiazepine injection.
  • Intravenous (IV) access can be difficult during a seizure; if it is not possible to connect an IV line, midazolam can be given intramuscularly (IM)
  • If the patient is not receiving urgent medical care (i.e., not in a medical facility), diazepam rectal gel (DiastatAcuDial), or intranasal or buccal midazolam are non-injectable options.
  • The DiastatAcuDialis given to patients (or caregivers, such as parents) who are at risk of long-lasting seizures; dispensing and counseling requirements are essential
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

acute seizure management

A

1) 0-5 minutes: Stabilization phase
- Time the seizure
- Start ECG,oxygen may be needed
- Check AED levels, electrolytes, if BG low - treat with D25-D50

2) 5-20 minutes: Initial treatment phase
If seizure continues:
- Give IV lorazepam (Ativon) or
- IM midazolam (Versed)
Alternatives if the above are not available:
- Rectal diazepam (Diastot),
- Intranasal or buccal midazolam

3) 20·40 minutes Second treatment phase
If seizure continues:
- Give regular AED: IV fosphenytoin, valproic acid, levetiracetam (phenobarbital if others are unavailable)
- If seizure lasts longer, there is no clear treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diastat Acudial Dispensing

A
  • Syringes MUST be dialed to the right dose and locked BEFORE DISPENSING.
  • Syringes come in 2.5, 10 and 20 mg.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chronic seizure management

A
  • 1st line: AED
  • AEDs should not be stopped abruptly as this can lead to seizures.

Non-drug and alternative options for chronic seizure treatment include:
- Medical marijuana {cannabis),
- A ketogenic diet,
- Vagal nerve stimulation
- Surgical intervention.

The Embrace2 smartwatch is an FDA-cleared medical device that monitors seizures in adults and children 6 years of age and older.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Medical Marijuana (Cannabis)

A
  • Cannabidiol, or CBD (Epidiolex), was the first cannabis- derived medication approved by the FDA to treat rare forms of epilepsy.
  • Epidiolex does not contain tetrahydrocannabinol (THC), but there are other CBD and medical marijuana products available that contain varying amounts of THC. - Pharmacists should consider the impact of additive CNS side effects, particularly with THC-containing products (e.g., somnolence, euphoria, possible anxiety and paranoia), and the potential for drug interactions from the THC and CBD components.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ketogenic Diet

A
  • Pt with refractory seizures (not responding to medications).
  • The diet contains high fats, normal protein and low carbohydrates (usually a 4:1 ratio of fats to combined protein and carbohydrates).
  • This forces the body to break down fatty acids into ketone bodies as an energy source.
  • Ketone bodies pass into the brain and replace glucose. - This elevated ketone state is called ketosis, and can lead to a reduction in seizure frequency.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ethosuximide indication

A

Absence seizures
- T-Type Ca channel blocker
(i’m absent, eh though it sucks)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Main drugs to treat focal and generalized seizures

A
  • Lamotrigine (Na)
  • Levetiracetam (Ca + inc GABA)
  • Topiramate (Na)
  • Valproic acid (GABA)

Val leve toi cz lammo l tapi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Narrow spectrum AED

A

1- Carbamazepine (Na)
2- Oxcarbazepine (Na + Ca)
3- Lacosamide (Na)
4- Phenobarbital (Potentiate GABA)
5- Phenytoin (Na)
6- Fosphenytoin (Na)

Car bas ma zepine / ox car bas zepine
Lacoste
fen toi? fos fen toi?
fen barb (bread)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pregabalin and gabapentin (Ca) are used commonly for:

A

not for epilepsy;
they are used to treat neuropathic pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

AEDs dec abnormal electrical activity by either:

A

■ Inc GABA

■ Dec Glutamate

■ Blocking (or altering) Ca channels, which slows down or stops transmission of the electrical signal

■ Blocking Na channels, which decreases the neurons firing rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Inc GABA

A
  • Benzodiazepine
  • Valproic Acid
  • Phenobarbital (enhance/ potentiate GABA)
  • Levetiracetam
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Blocking (or altering) Ca channels, which slows down or stops transmission of the electrical signal

A
  • Levetiracetam (Ca + GABA)
  • Ethosuximide (T type Ca chanel blocker)
  • Pregabalin/ Gabapentin (used for neuropathic pain)
  • Oxcarbazepine (Ca + Na)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Blocking Na channels, which decreases the neurons firing rate

A
  • Oxcarbazepine (Ca + Na)
  • Carbamazepine
  • Lamotrigine
  • Phenytoin/ Fosphenytoin
  • Topiramate
  • Lacosamide (?)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

SE of Carbamazepine. Oxcarbazepine and Eslicarbazepine

A
  • Hyponatremia,
  • rash,
  • enzyme induction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

SE of Gabapentin and Pregabalin

A
  • Weight gain, peripheral edema, mild euphoria
  • Used primarily for neuropathic pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

SE of Phenobarbital and Primidone (prodrug of phenobarbital)

A
  • Sedation, dependence/tolerance/overdose risk, enzyme induction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

SE of Topiramate and Zonisamide

A
  • Weight loss, metabolic acidosis
  • Nephrolithiasis and oligohidrosis/hyperthermia (in children)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what to supplement with?

A

Supplement with:
- ALL AEDs: calcium and vitamin D
- Women of childbearing age: folate
- Valproic acid: carnitine
- Lamotrigene & valproic acid: if alopecia develops supplement with selenium and zinc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Lamotrigine Brand

A
  • Lamictal,
  • Lamictal ODT,
  • Lamictal Starter Kit,
  • Lamictal XR,
  • Subvenite,
  • Subvenite Starter Kit-Blue, Green, Orange
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Lamotrigene dosing

A

Initial:
- Weeks 1 and 2: 25 mg daily
- Weeks 3 and 4: 50 mg daily
- Week 5 and on: can inc by 50 mg daily every 1-2 weeks

MaintenanceDose:
300 - 400 mg daily, divide BID, unless using XR (daily)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Lamotrigene boxed warning

A
  • Serious skin reactions, including SJS/TEN (rate of rash is greater in pediatrics than adults);
  • inc risk with higher than recommended starting doses, dose escalation or when used with valproic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Warning & se of lamotrigene

A

WARNING
- Risk of aseptic meningitis,
- blood dyscrasias,
- cardiac rhythm abnormalities,
- multiorgan hypersensitivity (DRESS) reactions,
- serious rare immune system reaction [hemophagocytic lymphohistiocytosis (HLH)] that can be fatal

SIDE EFFECTS
- Alopecia (supplement selenium and zinc),
- N/V,
- somnolence,
- rash,
- tremor,
- ataxia,
- impaired coordination,
- dizziness,
- diplopia,
- blurred vision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Lamotrigene drug interactions

A
  • Valproic acid inc lamotrigine concentrations more than two- fold. Use lower dose starter kit (blue box).
  • Carbamazepine, phenytoin, phenobarbital, primidone, lopinavir/ritonavir, atazanavir/ritonavir and rifampin J,lamotrigine levels by 40%. Use the higher dose starter kit (green box).
  • Oral estrogen-containing contraceptives J, lamotrigine; higher maintenance doses of lamotrigine may be needed.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

levetiracetam brand

A
  • Keppra,
  • Keppra XR,
  • Roweepra,
  • Spritam

Tablet, ODT, oral solution, injection

32
Q

Levetiracetam dose

A

Initial:
- 500 mg BID or
- 1,000 mg daily (XR)

Maximum:
- 3,000 mg/day

CrCI: <= 80 ml/min: dec dose
IV:PO ratio 1:1

33
Q

Levetiracetam warning & se

A

WARNINGS
- Psychiatric reactions, including psychotic symptoms,
- somnolence, fatigue,
- suicidal behavior,
- anaphylaxis, angioedema,
- coordination difficulties,
- severe skin reactions (SJS/TEN),
- hematologic abnormalities (mainly anemias),
- inc BP,
- loss of seizure control during pregnancy

SIDE EFFECTS
Irritability, dizziness, weakness, asthenia, vomiting (children and adolescents)

NOTES
No significant drug interactions

34
Q

Levetiracetam warning & se

A

WARNINGS
- Psychiatric reactions, including psychotic symptoms,
- somnolence, fatigue,
- suicidal behavior,
- anaphylaxis, angioedema,
- coordination difficulties,
- severe skin reactions (SJS/TEN),
- hematologic abnormalities (mainly anemias),
- inc BP,
- loss of seizure control during pregnancy

SIDE EFFECTS
Irritability, dizziness, weakness, asthenia, vomiting (children and adolescents)

NOTES
No significant drug interactions

35
Q

Topiramate brand

A
  • Topamax
  • Topama Sprinkle

Topiramate extended-release
- Qudexy XR
- Trokendi XR

Capsule, extended-release capsule, tablet

  • Also used for migraine prophylaxis
36
Q

Topiramate dose

A

Initial:
- Week 1: 25 mg BID (IR) or 50 mg daily (XR)
- Weeks 2-4: inc by 25 mg BID (IR) or 50 mg daily (XR) each week
- Week 5 and on: inc by 100 mg weekly until max dose or therapeutic effect

Maximum: 400 mg/day
CrCI < 70 ml/min: dec dose by 50%

37
Q

CI of topiramate

A
  • Trokendi XR only: alcohol use 6 hours before or after dose,
  • Qudexy XR only: patients with metabolic acidosis who are taking metformin
38
Q

se & warning of topiramate

A

WARNINGS
- Hyperchloremic nonanion gap metabolic acidosis,
- oligohidrosis (reduced perspiration)/hyperthermia (mostly in children),
- nephrolithiasis (kidney stones),
- acute myopia and secondary angle- closure glaucoma,
- hyperammonemia (alone and with valproic acid),
- visual problems (reversible),
- fetal harm

SIDE EFFECTS
- Somnolence, dizziness, psychomotor slowing, difficulty with memory/concentration/attention, weight loss, anorexia, paresthesia

MONITORING
- Electrolytes (especially bicarbonate), renal function, hydration status, eye exam (intraocular pressure)

NOTES
- Topamax Sprinkle: swallow whole or open and sprinkle on a small amount of soft food (do not chew; swallow immediately)

39
Q

Topiramate Drug Interactions

A
  • Topiramate is a weak inhibitor of CYP2Cl9and inducer of CYP3A4.
  • Phenytoin, carbamazepine, valproic acid and lamotrigine can dec topiramate levels.
  • Topiramate can dec oral contraception effectiveness (especially doses >= 200 mg/day)
  • Non hormonal contraception is recommended.
  • Topiramate can dec the INR in patients on warfarin; monitor closely.
40
Q

Brand names:
1- Valproic acid
2- Valproate sodium
3- Divalproex

A

1- Depakene: Capsule, syrup
2- Oepacon: IV
3- Depakote, Depakote ER, Depakote Sprinkle,
- Depakote: delayed-release (DR) tablet
- Depakote ER- extended-release (ER) tablet
- Depakote Sprinkle- capsules can be opened and sprinkled on food

Also used for bipolar disorder and migraine prophylaxis

41
Q

Dosing of valproic acid

A

Initial:
- 10-15 mg/kg/day

Maximum:
- 60 mg/kg/day

Therapeutic Range:
- 50-100 mcg/ml (total level)

If the albumin is low (< 3.5 g/dl), the true valproic acid level will be higher than it appears - adjust with
the same formula used for phenytoin.

DR and ER formulations are not bioequivalent, inc total daily dose 8-20% when converting from DR to ER tablets

42
Q

Boxed Warning of valproic acid

A

Hepatic failure:
- Usually during first 6 months of therapy,
- Children < 2 years old and patients with mitochondrial disorders [mutations in mitochondrial DNA polymerase gamma gene (POLG)] are at inc risk;
- fetal harm (neural tube defects and dec IQ scores); pancreatitis

43
Q

CI of Valproic Acid

A
  • Hepatic disease,
  • Urea cycle disorders,
  • Prophylaxis of migraine in pregnancy,
  • Known POLG-related disorder or suspected if < 2 years of age
44
Q

how to treat hyperammonemia caused from valproic acid?

A

Treat with carnitine in symptomatic adults only

45
Q

what to supplement with if a pt had alopecia cz of valproic acid

A

selenium & zinc

46
Q

what to monitor with valproic acid

A
  • LFTs (baseline and frequently in the first 6 months),
  • CBC with differential,
  • Platelets
47
Q

Valproic acid drug interations

A
  • Valproic acid is an inhibitor of CYP2C9 (weak) and a substrate of CYP2Cl9and 2El (minor).
  • Valproic acid can i levels of lamotrigine, phenobarbital, phenytoin, warfarin and zidovudine.
  • Salicylates displace valproic acid from albumin {i levels).
  • Carbapenem antibiotics can J,the levels of valproic acid.
  • Estrogen-containing hormonal contraceptives can dec valproic acid levels.
  • Use caution with valproic acid and lamotrigine due to risk of serious rash; use lower starting dose of lamotrigine and titrate slowly.
  • Use with topiramate can lead to hyperammonemia with or without encephalopathy.
48
Q

Carbamazepine brand names

A
  • Tegretol
  • Tegretol XR
  • Carbatrol
  • Epitol

Capsule, tablet, chewable, oral suspension

  • Equetro - for bipolar disorder
  • Also used for trigeminal neuralgia
49
Q

Carbamazepine dose

A

Initial:
- 200 mg BID (or divided QID for suspension)

Maximum:
- 1,600 mg/day (some patients can require more)

Therapeutic Range:
- 4-12 mcg/ml

50
Q

Boxed warning of carbamazepine

A
  • Serious skin reactions, including SJS/TEN:
  • Patients of Asian descent should be tested for HLA-B*1502 allele prior to initiation; if positive for this allele, carbamazepine cannot be used (unless benefit clearly outweighs risk);
  • Aplastic anemia and agranulocytosis; discontinue if significant myelosuppression occurs
51
Q

CI of carbamazepine

A
  • Myelosuppression,
  • Hypersensitivity to TCAs,
  • Use of MAO inhibitors within past 14 days,
  • Use with nefazodone or non-nucleoside reverse transcriptase inhibitors (NNRTls) that are substrates of CYP3A4
52
Q

Risk of developing a hypersensitivity reaction can be inc in patients with

A

The variant HLA-A*3101 allele

53
Q

Warning with carbamazepine

A
  • Multiorgan hypersensitivity (DRESS) reactions
  • Hyponatremia (SIADH)
  • Hypothyroidism
  • Mild anticholinergic effects
  • Cardiac conduction abnormalities
  • Liver damage
  • Fetal harm
54
Q

SE with carbamazepine

A
  • Dizziness,
  • drowsiness,
  • ataxia,
  • N/V,
  • pruritus,
  • photosensitivity,
  • blurred vision,
  • rash,
  • inc LFTs,
  • alopecia
55
Q

Monitoring with carbamazepine

A
  • CBC with differential and platelets prior to and during therapy,
  • LFTs,
  • rash,
  • eye exam,
  • thyroid function tests,
  • electrolytes (especially Na),
  • renal function
  • Monitor levels within 3-5 days of initiation and after 4 weeks due to autoinduction
    NOTE:
  • Enzyme inducer, autoinducer - dec level of other drugs and itself
56
Q

Drug interaction with carbamazepine

A
  • Carbamazepine is an autoinducer and will dec its own levels.
  • Carbamazepine is a strong inducer of many enzymes (CYP1A2,2Cl9, 2C8/9, 3A4) and P-glycoprotein (P-gp).
  • It will dec the levels of many drugs, including other seizure medications, aripiprazole, levothyroxine, warfarin and hormonal contraceptives.
  • Use of an alternative, non- hormonal contraceptive is recommended.
  • Carbamazepine is a major CYP3A4substrate; inhibitors will inc carbamazepine levels and inducers will dec carbamazepine levels. Do not use with nefazodone or NNRTls.
  • Carbamazepine suspension should not be taken with other liquid medications (especially chlorpromazine) or diluents, as precipitates can form.
57
Q

Lacosamide brand name

A
  • Vimpat
  • C-v

Tablet, oral solution, injection

58
Q

Lacosamide dosing

A

Initial:
- 50-100 mgBID

Maximum:
- 400 mg/day

CrCI< 30 ml/min: maximum dose is 300 mg/day

IV:PO ratio 1:1

59
Q

Lacosamide warning, SE, Monitoring

A

WARNINGS
- Prolongs PR interval and inc risk of arrhythmias;
- Obtain an ECG prior to use and after titrated to steady state in patients with or at risk of cardiac conduction problems;
- Multiorgan hypersensitivity (DRESS) reactions,
- syncope,
- dizziness,
- ataxia

SIDE EFFECTS
- Dizziness, headache,
- diplopia, blurred vision,
- ataxia, tremor, euphoria

MONITORING
ECG (baseline and at steady state) in at-risk patients

60
Q

Lacosamide DDI

A

Lacosamide is a substrate of CYP2Cl9 (minor), 2C9
(minor), 3A4 (minor) and an inhibitor of CYP2Cl9 (weak). Caution with inhibitors of CYP2Cl9, 2C9 and 3A4 as they can inc lacosamide levels.

Caution with medication that prolong PR interval:
- B blockers
- CCB
- Digoxin
due to risk of bradycardia & AV block

61
Q

oxcarbazepine brand names

A
  • Trilleptal: Tablet,oral suspension
  • Oxtellar XR: Extended-release tablet
62
Q

Oxcarbazepine dosing

A

Initial:
- 300 mg BlD (Trilleptal);
- 600 mg daily (Oxtellar XR)

Maximum:
2,400 mg/day

CrCI < 30 ml/min: start 300 mg daily

Carbamazepine to oxcarbazepine dose conversion:
1.2-1.5x carbamazepine dose

63
Q

Oxcarbazepine CI

A

Hypersensitivity to eslicarbazepine

64
Q
A

WARNING:
- inc risk for serious skin reactions (SJS/TEN),
- consider screening patients of Asian descent for HLA-B*1502 prior to initiating therapy,
- multi organ hypersensitivity (DRESS) reactions,
- hypersensitivity reactions to carbamazepine have
25 - 30% cross-sensitivity to oxcarbazepine
- Hyponatremia,
- hypothyroidism,
- potential worsening of seizures

SIDE EFFECTS
- Somnolence, dizziness,
- N/V, abdominal pain,
- diplopia,
- visual disturbances,
- ataxia, tremor

MONITORING
- Serum Na levels, especially during first 3 months of therapy,
- thyroid function,
- CBC

NOTES
- Trilleptal oral suspension: must be used within 7 weeks once original container is opened
- XR tablet: take on empty stomach 1 hour before or 2 hours after a meal

65
Q

Phenobarbital

A

C-IV
Tablet, oral solution, elixir, injection

dose:
Initial:
- 50-100 mg BID or TID

Therapeutic Range:
- 20-40 mcg/ml (adults)
- 15-40 mcg/ml (children)

CONTRAINDICATIONS
- Severe hepatic impairment,
- dyspnea or airway obstruction,
- previous addiction to hypnotics,
- intra arterial administration

WARNING:
- Habit-forming,
- respiratory depression,
- fetal harm,
- paradoxical reactions including hyperactive or aggressive behavior (in acute pain and pediatric patients),
- hypotension when given IV,
- serious skin reactions (SJS/TEN)

SIDE EFFECTS
- Physiological dependence, tolerance, hangover effect,
- somnolence, cognitive impairment,
- dizziness, ataxia, depression,
- folate deficiency

MONITORING
LFTs, CBC with differential

NOTES
Primidone is a prodrug of phenobarbital

66
Q

Phenobarbital DDI

A
  • Phenobarbital (and primidone, which is the prodrug) is a strong inducer of most enzymes, including CYP1A2, 2C8/9, 3A4 and P-gp.
    These two drugs can J,the levels of many drugs metabolized by these enzymes.
  • Phenobarbital and primidone cant hormonal contraceptive levels significantly.
    Use of an alternative, non-hormonal contraceptive is recommended.
67
Q

Phenytoin brand names

A
  • Dilantin,
  • Dilantin lnfatabs,
  • Phenytek

Capsule, chewable, oral suspension, injection (IV only)

68
Q

Fosphenytoin brand names

A
  • Cerebyx,
  • Sesquient

Injection (IV/IM)
Prodrug of phenytoin

69
Q

Phenytoin/ Fosphenytoin dose

A

Loading dose:
- 15-20 mg/kg

Maintenance dose:
- up to 300-600 mg/day

Fosphenytoin is dosed in phenytoin equivalents (PE):
1 mg PE = 1 mg phenytoin
(fosphenytoin 1.5 mg = 1 mg PE)

IV:PO ratio 1:1

Therapeutic Range:
- 10-20 mcg/ml (total level)
- 1-2.5 mcg/ml (free level)

70
Q

Phenytoin/ fosphenytoin BBW

A
  • Phenytoin IV administration rate should not exceed 50 mg/minute and
  • Fosphenytoin IV should not exceed 150 mg PE/minute or 2 mg PE/kg/min (use the slower rate);
  • if given faster, hypotension and cardiacarrhythmias can occur
71
Q

CI Phenytoin/ fosphen

A

Previous hepatotoxicity due to phenytoin

72
Q

warning with phen/fosphenytoin

A
  • Extravasation (leading to purple glove syndrome, characterized by edema, pain and bluish discoloration of the skin, which can sometimes lead to tissue necrosis),
  • avoid phenytoin in patients with a positive HLA-B*1502 and in patients who have had a severe rash with carbamazepine,
  • multi organ hypersensitivity (DRESS) reactions,
  • fetal harm,
  • bradycardia,
  • inc risk of serious skin reactions (SJS/TEN),
  • fraction of unbound (free) drug is higher with renal or hepatic failure or dec albumin,
  • blood dyscrasias,
  • caution in cardiac disease, hepatic and renal impairment,
  • hypothyroidism
73
Q

phen/fosphenytoin SE, monitoring

A

Dose-related (toxicity):
- Nystagmus, ataxia, diplopia/blurred vision, slurred speech, dizziness, somnolence, lethargy, confusion

Chronic:
- Gingival hyperplasia,
- hair growth,
- hepatotoxicity,
- skin thickening (children),
- morbilliform rash (measles-like),
- peripheral neuropathy,
- inc BG,
- metallic taste,
- connective tissue changes,
- enlargement of facial features (lips}

MONITORING
- Serum phenytoin concentration,
- LFTs,
- CBC with differential
IV: continuous cardiac (ECG,BP,HR) and respiratory monitoring

!!! adjust phenytoin dose for low doses of albumin

74
Q

phen/fosphen DDI

A
  • Phenytoin and fosphenytoin are strong inducers of several enzymes, including CYP2B6, 2Cl9, 2C8/9, 3A4, Pgp and UGTlAl; they are substrates of CYP2Cl9 (major), 2C9 (major) and 3A4 (minor).
  • Phenytoin and fosphenytoin can dec the concentration of many drugs including other AEDs, contraceptives and warfarin.
  • Use of an alternative, non-hormonal contraceptive is recommended with chronic phenytoin.
  • Both have high protein binding and can displace other highly protein-bound drugs or be displaced by other highly protein-bound drugs, causing an inc in levels that can lead to toxicity.
75
Q

phen/ phenytoin administration

A

IV Phenytoin
- Do not exceed 50 mg/minute (slow infusion)
- Monitor BP, respiratory function and ECG
- Requires a filter
- Dilute in NS, stable for 4 hours, do not refrigerate

NG-tube Phenytoin
- Enteral feedings (e.g.,tube feeds) dec phenytoin absorption
- Hold feedings 1-2 hours before and after administration

IV Fosphenytoin
- Do not exceed 150 mg PE/minute
- Monitoring same as above
- Lower risk of purple glove syndrome than phenytoin